Today: 13 April 2026
Visa stock drops 4.5% after Mexico blocks Prosa deal — what Wall Street watches next
23 February 2026
2 mins read

Visa stock drops 4.5% after Mexico blocks Prosa deal — what Wall Street watches next

New York, Feb 23, 2026, 15:58 EST — Regular session.

  • Visa shares dropped roughly 4.5% in late afternoon, tracking losses across U.S. financials.
  • Visa’s bid to acquire a 51% stake in Mexican payments processor Prosa hit a wall after the country’s antitrust commission shot down the deal.
  • Investors eye Visa’s plans for Mexico, along with its scheduled appearance at an investor conference on March 3.

Visa Inc (V) dropped 4.5% to $306.64 late Monday, echoing losses across U.S. financials. Shares kicked off at $317.09, then dipped as low as $304.97 during the session.

Visa had billed the Prosa stake as a chance to dig further into Mexico. That looks uncertain again after the outright rejection, leaving its regional strategy unresolved. All this hit just as trade and inflation headlines shook up risk appetite, sending major financial stocks lower.

Visa’s bid to buy a 51% stake in Prosa has been blocked by Mexico’s National Antitrust Commission, according to a Zacks update on Nasdaq.com. Regulators flagged fears over too much market power and the potential exposure of sensitive data. Visa had aimed to combine its network with Prosa’s Carnet platform, a move that would have handed it sway over two of Mexico’s four main card-payment clearinghouses — the backbone for transaction routing and settlement.

The commission said the deal might take out a direct rival, since Visa already handles its own processing in the country, and could hurt Carnet’s standing as a cheaper card alternative, according to El Financiero. Prosa is responsible for processing over 10 billion transactions each year, the outlet noted, with shareholders including Banorte, HSBC Mexico, Santander Mexico, and Scotiabank Mexico.

Visa called the decision “disappointing” and said it’s weighing its next steps. In a statement, the firm argued, “We firmly believe that the combination of Visa and Prosa would significantly accelerate competition in the market.” Visa Corporate

Visa’s push into Latin America hit a snag in Mexico, but the company isn’t letting up. Just last week, it inked an agreement to acquire Prisma and Newpay, two payment platforms owned by Advent International, aiming to strengthen its position in Argentina. Reuters says that deal should wrap up in the first quarter of 2026.

Visa slid along with broader U.S. stocks, rattled by a Supreme Court decision on tariffs and fresh trade threats from President Donald Trump that stirred up fears about shifting policies. “This adds a level of uncertainty because it calls into question the trade deals that have been made,” said Ross Mayfield, investment strategy analyst at Baird. Reuters

Other payments stocks took a hit as well. Mastercard dropped roughly 6.3%, American Express slid 7.3%. PayPal, on the other hand, climbed 5.5%.

This story isn’t settled yet. A resolution in Mexico could help Visa move past the Prosa setback, while tougher rules or fee caps from regulators would keep pressure on the shares. Both Visa and Mastercard are still working to wrap up the new U.S. merchant “swipe fee” settlement — those interchange charges that tend to resurface in regulatory debates. Reuters

Macro watchers are zeroed in on inflation data and rate forecasts, scanning for signals on consumer appetite and international travel—both critical for card network performance. The U.S. producer price index for January drops at 8:30 a.m. ET on Friday, Feb. 27, the Labor Department says on its release calendar.

Visa’s Chief Product and Strategy Officer Jack Forestell is slated for a speaking slot at the Morgan Stanley Technology, Media & Telecom Conference on March 3, according to Visa. Market players will be listening for any remarks on Mexico or hints about the company’s approach to dealmaking going forward.

Stock Market Today

  • US Threatens Strait of Hormuz Blockade, Oil Surges Past $100, Indian Markets Brace for Drop
    April 13, 2026, 12:03 AM EDT. Global markets opened cautiously amid escalating tensions in the Middle East. The US Dow Jones fell 0.6% as nuclear talks with Iran collapsed. Washington demands concessions; Tehran seeks ceasefire, reparations, and control over the strategic Strait of Hormuz. The US signals a possible naval blockade. Oil prices surged over 7%, topping $100 per barrel, reflecting risks to supply. Safe-haven metals performed unevenly; gold slipped while silver fell sharply. US 10-year bond yields climbed towards 4.35%, intensifying risk-off sentiment. Asian equities followed suit with weaker starts, and India's GIFT Nifty futures point to a gap-down opening despite a strong Friday. Market participants brace for heightened volatility amid geopolitical uncertainty.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.04.2026

13 April 2026
LIVEMarkets rolling coverageStarted: April 13, 2026, 12:00 AM EDTUpdated: April 13, 2026, 12:03 AM EDT US Threatens Strait of Hormuz Blockade, Oil Surges Past $100, Indian Markets Brace for Drop April 13, 2026, 12:03 AM EDT.Global markets opened cautiously amid escalating tensions in the Middle East. The US Dow Jones fell 0.6% as nuclear talks with Iran collapsed. Washington demands concessions; Tehran seeks ceasefire, reparations, and control over the strategic Strait of Hormuz. The US signals a possible naval blockade. Oil prices surged over 7%, topping $100 per barrel, reflecting risks to supply. Safe-haven metals performed unevenly; gold slipped while
Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
Nebius (NBIS) stock rises in choppy session as AI cloud spending stays in focus
Previous Story

Nebius (NBIS) stock rises in choppy session as AI cloud spending stays in focus

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop